Acadian Asset Management LLC Nektar Therapeutics Put Options Transaction History
Acadian Asset Management LLC
- $35.4 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NKTR
# of Institutions
168Shares Held
123MCall Options Held
1.18MPut Options Held
64.6K-
Black Rock Inc. New York, NY15.2MShares$9.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$7.76 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.79MShares$4.91 Million0.24% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$4.19 Million0.1% of portfolio
-
Primecap Management CO Pasadena, CA5.35MShares$3.37 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $118M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...